We subsequently demonstrated that the NLRP3 inflammasome is activated in coronary microvascular endothelium during NAFLD and the release of cytokines including IL-1β and HMGB1 are elevated in cardiac tissue. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.